Company: BNBX
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001104659-25-105958
Chunk: 0

Company: BNB PLUS CORP.
Filing Date: 2025-11-04
Form: 424B5
Chunk 0
---
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-272267

PROSPECTUS SUPPLEMENT

(To prospectus dated June 6, 2023)

<div align='center'>APPLIED DNA SCIENCES, INC.

Up to $8,157,932

Common Stock</div>

We have entered into an At The Market Offering
Agreement (the “Sales Agreement”), with Lucid Capital Markets, LLC (“Lucid”), relating to shares of our common
stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may
offer and sell shares of our common stock, $0.001 par value per share, having an aggregate offering price of up to $8,157,932 from time
to time through Lucid acting as our sales agent. The offering of shares of our common stock pursuant to the Sales Agreement will terminate
upon the earlier of (i) the sale of all common stock provided for in this prospectus supplement, and (ii) the termination of
the Sales Agreement by written notice of us or Lucid.

Our common stock is listed on The Nasdaq Capital
Market (“Nasdaq”), under the symbol “BNBX.” On October 31, 2025, the last reported sale price of our common
stock on Nasdaq was $3.45 per share.

Pursuant to General Instruction I.B.6 of Form S-3,
in no event will we sell our common stock in a public primary offering with a value exceeding more than one-third of the aggregate market
value of our voting and non-voting common equity held by non-affiliates in any 12-month period as long as the aggregate market value of
our outstanding voting and non-voting common equity held by non-affiliates is less than $75,000,000. Calculated in accordance with General
Instruction I.B.6 of Form S-3, the aggregate market value of our outstanding common stock held by non-affiliates, or the public float,
was approximately $24.5 million based upon 4,354,768 shares of our outstanding stock held by non-affiliates at the per share price of
$5.62 on October 6, 2025, which was the highest closing price within the last 60 days prior to the date of this filing. One-third
of our public float, calculated in accordance with General Instruction I.B.6 of Form S-